Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesDividends payablesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Common Equity: 2016-2025

Historic Common Equity for cbdMD (YCBD) over the last 10 years, with Sep 2025 value amounting to $7.2 million.

  • cbdMD's Common Equity rose 268.04% to $7.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.2 million, marking a year-over-year increase of 268.04%. This contributed to the annual value of $7.2 million for FY2025, which is 268.04% up from last year.
  • Per cbdMD's latest filing, its Common Equity stood at $7.2 million for FY2025, which was up 268.04% from $2.0 million recorded in FY2024.
  • In the past 5 years, cbdMD's Common Equity ranged from a high of $103.1 million in FY2021 and a low of $2.0 million during FY2024.
  • In the last 3 years, cbdMD's Common Equity had a median value of $7.2 million in 2025 and averaged $6.1 million.
  • Its Common Equity has fluctuated over the past 5 years, first plummeted by 78.26% in 2024, then surged by 268.04% in 2025.
  • cbdMD's Common Equity (MRY) stood at $103.1 million in 2021, then crashed by 69.53% to $31.4 million in 2022, then tumbled by 71.26% to $9.0 million in 2023, then crashed by 78.26% to $2.0 million in 2024, then skyrocketed by 268.04% to $7.2 million in 2025.
  • Its last three reported values are $7.2 million in FY2025, $2.0 million for FY2024, and $9.0 million during FY2023.